Profil
Ms. Alicia Goodman is a Chief Human Resources Officer at Cerus Corp.
Ms. Goodman was previously employed as a Senior Vice President-Human Resources by Aimmune Therapeutics, Inc., a Senior VP, Chief People & Culture Officer by Berg LLC, and a Vice President-Human Resources by Novartis AG.
She received her undergraduate degree from Michigan State University and a graduate degree from Central Michigan University.
Aktive Positionen von Alicia Goodman
| Unternehmen | Position | Beginn |
|---|---|---|
| CERUS CORPORATION | Personalreferent | 27.09.2023 |
Ehemalige bekannte Positionen von Alicia Goodman
| Unternehmen | Position | Ende |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Personalreferent | 01.02.2023 |
| NOVARTIS AG | Personalreferent | - |
Berg LLC
Berg LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Personalreferent | - |
Ausbildung von Alicia Goodman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Michigan State University
Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Central Michigan University
Central Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Berg LLC
Berg LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
















